Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance

dc.contributor.authorSigurbergsdóttir, Aðalbjörg Ýr
dc.contributor.authorLöve, Þorvarður Jón
dc.contributor.authorKristinsson, Sigurður Yngvi
dc.contributor.departmentFaculty of Medicine
dc.date.accessioned2025-11-20T08:47:19Z
dc.date.available2025-11-20T08:47:19Z
dc.date.issued2022-04-28
dc.descriptionCopyright © 2022 Sigurbergsdóttir, Love and Kristinsson.en
dc.description.abstractVarious epidemiological studies, including case reports and -series in addition to larger, population-based studies, have reported an increased prevalence of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma in individuals with a prior history of immune-related conditions. This is believed to support the role of chronic antigen stimulation in the pathogenesis of these conditions. In this short review, we summarize some of the largest population-based studies researching autoimmune diseases, infections, and the subsequent risk of MGUS, and discuss our understanding on its etiology and pathogenesis. Furthermore, we highlight important methodological limitations of previous studies in the field, but almost all studies on MGUS have been based on clinical, possibly biased, cohorts. Finally, we discuss future directions in researching the associations of MGUS and other disorders, including immune-related conditions, where screening studies play an important role.en
dc.description.versionPeer revieweden
dc.format.extent299203
dc.format.extent876271
dc.identifier.citationSigurbergsdóttir, A Ý, Löve, Þ J & Kristinsson, S Y 2022, 'Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance', Frontiers in Immunology, vol. 13, 876271, pp. 876271. https://doi.org/10.3389/fimmu.2022.876271en
dc.identifier.doi10.3389/fimmu.2022.876271
dc.identifier.issn1664-3224
dc.identifier.other56885967
dc.identifier.other1fff7a48-4968-451d-8843-780581d7bf0b
dc.identifier.other85130007031
dc.identifier.other35572590
dc.identifier.otherunpaywall: 10.3389/fimmu.2022.876271
dc.identifier.urihttps://hdl.handle.net/20.500.11815/6741
dc.language.isoen
dc.relation.ispartofseriesFrontiers in Immunology; 13()en
dc.relation.urlhttps://www.scopus.com/pages/publications/85130007031en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.subjectautoimmune diseasesen
dc.subjectchronic antigen stimulationen
dc.subjectinfectionsen
dc.subjectiStopMM studyen
dc.subjectmonoclonal gammopathy of undetermined significanceen
dc.subjectrisken
dc.subjectAutoimmunityen
dc.subjectMonoclonal Gammopathy of Undetermined Significance/epidemiologyen
dc.subjectHumansen
dc.subjectImmune System Diseases/complicationsen
dc.subjectAutoimmune Diseasesen
dc.subjectParaproteinemiasen
dc.subjectMultiple Myelomaen
dc.subjectImmunology and Allergyen
dc.subjectImmunologyen
dc.titleAutoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significanceen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/articleen

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Nafn:
Autoimmunity_....pdf
Stærð:
292.19 KB
Snið:
Adobe Portable Document Format

Undirflokkur